May 2013

Manel Esteller, BIAL Foundation Distinction for his work in cancer genetics

Leave a Comment / Cancer, Cancer Epigenetics / By

Manel Esteller, Director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with a BIAL Foundation Distinction in its eighth edition. The international honour distinguishes a research work which content constitutes a significant contribution in the field of Health Sciences. […]

Manel Esteller, BIAL Foundation Distinction for his work in cancer genetics Read More »

Diego Viasus awarded the Extraordinary Doctorate Prize of the Faculty of Medicine of the UB

Leave a Comment / Infections of the Respiratoy Tract and in Immunocompromised Patients , Infectious disease and transplantation Program, Translational Medicine Area / By

The PhD thesis of Diego Viasus researcher at Infections of the respiratory tract and in Immunocomproimised Patients research group at IDIBELL has won two awards. On one hand, has received the Extraordinary Doctorate Award from the Faculty of Medicine of the University of Barcelona and on the other, the Gabriel Rufí Prize for the best

Diego Viasus awarded the Extraordinary Doctorate Prize of the Faculty of Medicine of the UB Read More »

José Luis Hernández: ”We have designed two antibodies that block S100 proteins and we’ve observed that slow tumors growth”

Leave a Comment / Sin categorizar / By

The laboratory of José Luis Hernández at the Biomed division, LEITAT Technology Center of Barcelona works in the clinical application of two antibodies designed by them to block proliferative function of extracellular S100 proteins. Hernandez explained his research on April 26 at a conference framed at IDIBELL seminars cycle. “We designed two antibodies that block

José Luis Hernández: ”We have designed two antibodies that block S100 proteins and we’ve observed that slow tumors growth” Read More »

IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease

Leave a Comment / Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

IDIBELL has signed a licensing agreement with the Catalan biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease, which has no effective treatment. The Neurometabolic Diseases group led by ICREA researcher Aurora Pujol, has developed an animal model to study this disease. Studies using this model have

IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease Read More »

‘Dark genome’ is involved in Rett Syndrome

Leave a Comment / Cancer Epigenetics / By

Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding long chain RNA sequences (lncRNA) in Rett syndrome. These molecules act as supervisor agents responsible of ‘switch on’ or ‘switch off’ other genes in our

‘Dark genome’ is involved in Rett Syndrome Read More »

Scroll to Top